Penumbra Return on Equity

Penumbra (PEN) currently reports a ROE of 10.49%. That is below the Healthcare sector average of 21.18%. Use the charts on this page to explore Penumbra's ROE history and peer comparisons.

Penumbra's ROE of 10.49% is lower than the Healthcare sector average of 21.18%. That is roughly 50.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Penumbra's current 10.49% should be judged against Healthcare norms (sector average: 21.18%) and against PEN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 10.49%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.18%. From there, open related valuation or income-statement pages for Penumbra, and consider following PEN for alerts when major investors trade the stock.

Penumbra is classified in the Healthcare sector. On ROE, it currently shows 10.49% versus a sector average near 21.18%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PEN with unrelated industries.